Pro Medicus Limited Financials

Market Capitalization A$13.45 Billion as of July 1, 2024

Valuations Metrics as of May. 5, 2024

Trailing PE	163.25
Forward PE	110.48
Price to Sales TTM	A$80.37
Price to Book MRQ	A$71.72
Enterprise to Revenue	79.46
Enterprise to EBITDA	117.54

Financial Reports as of Jun. 30, 2023

Financials

Fiscal Year Ends	2023-06-30
Most Recent Quarter	2023-06-30
Profit Margin	49.05%
Operating Margin	66.03%
Return on Assets TTM	30.78%
Return on Equity TTM	50.49%

Income Statement

Revenue TTM	A$142,123,008
Revenue per Share TTM	A$1.36
Quarterly Revenue Growth	30.30%
Gross Profit TTM	A$124,243,000
EBITDA	A$91,687,000
Net Income to Common TTM	A$69,709,000
Diluted EPS TTM	A$0.67
Quarterly Earnings Growth YoY	33.30%

Balance Sheet

Total Cash MRQ	A$131,534,000
Total Cash per Share MRQ	A$1.26
Total Debt MRQ	A$
Total Debt to Equity MRQ	0.97
Current Ratio MRQ	7.49
Book Value per Share MRQ	A$1.53

Cash Flow

Operating Cash Flow TTM	A$71,401,000
Levered Free Cash Flow TTM	A$60,229,876

PME Stock Info as of May. 5, 2024

Stock Statistics

Shares Outstanding	104,425,000
Float Shares	50,099,359
Avg 10 Volume	265,396
Avg 30 Volume	None
Shares Short	None
Short Ratio
Short % of Shares	%
% Held by Insiders	52.03%
% Held by Institutions	12.24%

Stock Price Summary

Beta	0.47
Fifty Two Week Low	A$58.60
Fifty Two Week High	A$113.93
Fifty Two Week Change	47.17%
Day 50 MA	A$101.21
Day 200 MA	A$88.57

Dividends and Splits

Forward Annual Dividend Rate	A$0.72
Forward Annual Dividend Yield	0.63%
Trailing Annual Dividend Rate	A$0.35
Trailing Annual Dividend Yield	0.31%
Payout Ratio	45.01%
Dividend Date
Ex Dividend Date	2024-02-29
Last Split Factor
Last Split Date